INHIBITION OF THE SALMONELLA-TYPHI ORAL VACCINE STRAIN, TY21A, BY MEFLOQUINE AND CHLOROQUINE

被引：16
|
作者：
HOROWITZ, H [1 ]
CARBONARO, CA [1 ]
机构：
[1] WESTCHESTER CTY MED CTR,DEPT MED,DIV INFECT DIS & IMMUNOL,VALHALLA,NY 10595
来源：
JOURNAL OF INFECTIOUS DISEASES | 1992年 / 166卷 / 06期
关键词：
D O I：
10.1093/infdis/166.6.1462-b
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1462 / 1464
页数：3
相关论文
共 50 条
  • [31] The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a
    Robbe-Saule, V
    Norel, F
    [J]. FEMS MICROBIOLOGY LETTERS, 1999, 170 (01) : 141 - 143
  • [32] IMMUNOGENICITY OF TY21A ATTENUATED SALMONELLA-TYPHI GIVEN WITH SODIUM-BICARBONATE OR IN ENTERIC-COATED CAPSULES
    BLACK, R
    LEVINE, MM
    YOUNG, C
    ROONEY, J
    LEVINE, S
    CLEMENTS, ML
    ODONNELL, S
    HUGUES, T
    GERMANIER, R
    [J]. DEVELOPMENTS IN BIOLOGICALS, 1982, 53 : 9 - 14
  • [33] A CONTROLLED FIELD TRIAL OF LIVE SALMONELLA-TYPHI STRAIN TY 21A ORAL VACCINE AGAINST TYPHOID - 3-YEAR RESULTS
    WAHDAN, MH
    SERIE, C
    CERISIER, Y
    SALLAM, S
    GERMANIER, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03): : 292 - 295
  • [34] SAFETY, IMMUNOGENICITY, AND EFFICACY AGAINST CHOLERA CHALLENGE IN HUMANS OF A TYPHOID-CHOLERA HYBRID VACCINE DERIVED FROM SALMONELLA-TYPHI TY21A
    TACKET, CO
    FORREST, B
    MORONA, R
    ATTRIDGE, SR
    LABROOY, J
    TALL, BD
    REYMANN, M
    ROWLEY, D
    LEVINE, MM
    [J]. INFECTION AND IMMUNITY, 1990, 58 (06) : 1620 - 1627
  • [35] POSTMARKETING EXPERIENCE WITH LIVE ORAL TY21A VACCINE
    CRYZ, SJ
    [J]. LANCET, 1993, 341 (8836): : 49 - 50
  • [36] DEVELOPMENT OF A SALMONELLA ENTERICA SEROVAR TYPHI TY21A STRAIN AS A MULTIVALENT VACCINE PLATFORM AGAINST SHIGELLOSIS, ETEC DIARRHEA AND TYPHOID FEVER
    Wu, Yun
    Chakravarty, Sumana
    Wai, Tint T.
    Jackson, Jonathan M.
    Li, Minglin
    James, Eric R.
    Huang, Henry
    Laney, Victoria
    Zhang, Weiping
    Sack, David A.
    Hoffman, Stephen L.
    Sim, B. Kim Lee
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 356 - 356
  • [37] SAFETY AND IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A LIQUID FORMULATION VACCINE IN 4-YEAR-OLD TO 6-YEAR-OLD THAI CHILDREN
    OLANRATMANEE, T
    LEVINE, M
    LOSONSKY, G
    THISYAKORN, U
    CRYZ, SJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02): : 451 - 452
  • [38] COMPLIANCE WITH LIVE, ORAL TY21A TYPHOID VACCINE
    KAPLAN, DT
    HILL, DR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (08): : 1074 - 1074
  • [39] IMMUNOGENICITY OF THE LIVE ORAL TYPHOID VACCINE TY21A
    BARTHOLOMEUSZ, RCA
    JOHNSON, M
    LABROOY, JT
    SHEARMAN, DJC
    ROWLEY, D
    [J]. GASTROENTEROLOGY, 1985, 88 (05) : 1317 - 1317
  • [40] SURFACE COEXPRESSION OF VIBRIO-CHOLERAE AND SALMONELLA-TYPHI O-ANTIGENS ON TY21A CLONE EX210
    ATTRIDGE, SR
    DANIELS, D
    MORONA, JK
    MORONA, R
    [J]. MICROBIAL PATHOGENESIS, 1990, 8 (03) : 177 - 188
12345